Confidential

Defending a brand facing a reputational crisis.

Challenge

Faced with a health care company's reputational crisis, the LLYC Crisis Team developed the project that would become a benchmark success story and win an International Business Award in 2017. The solution lay in establishing a communications strategy focused on lowering negative tones in future media and social networking publications, taking a multi-stakeholder perspective on the issue.

Impact.

Through the strategy employed we: reassured and supported the firm's clients with a message of normality, maintained alignment between information and communications with the legal team, opened a communications channel with a consumer association and maintained interaction with financiers, suppliers and employees.

"I never thought I would be involved in a company crisis, much less that I was going to be one of the protagonists. Undoubtedly, the best decision I could make, as soon as the crisis broke, was to call the LLYC team. Their exceptional professionals quickly took control of the situation and set a strategy in place to do the right thing. Personally, I still rely on the closeness, empathy and collaboration of the team; it was a true learning experience and a pleasure to work with them.”

The company's spokesperson in 2016.

Related cases

Multiopticas
Multiopticas
Caso
Unicaja
Unicaja
Caso
IDEAS
14 Sep 2021

How to convert reputational risks into opportunities thro...

In this fourth and final edition of the “Resilience” series, we address the challenge of recovering from a reputational crisis once the worst is over or overcoming a chronic...
9 Sep 2021

Technology and digitalization in the health sector: Reali...

Introduction Threats to public health mean transforming the healthcare sector through technology is a pressing concern.Technology can help design prevention and wellness models.Over the last decade, we h...
1 Sep 2021

Latin America in the light of the United States and China...

Introduction    If anyone thought that the so-called Fourth Industrial Revolution, also known as “Industry 4.0,” which we have found ourselves in would not have its own particular dose of “cold...
4 Aug 2021

BIOLOGIC AND BIOSIMILAR MEDICATION: A Marriage of Conveni...

Can the biopharmaceutical industry maintain 2020’s favorable position and further boost innovative biologic and biosimilar medicines? The launch of biologic (or biotechnolo...

We want to collaborate with you

Do you have a challenge?

Would you like to join our team?

Do you want us to speak at your next event?